Sample Size Based on Pharmacodynamic endpoints [Power / Sample Size]

posted by sury – India, 2019-04-03 14:28 (2041 d 09:14 ago) – Posting: # 20117
Views: 5,099

Hii All,

Hope all are doing well....

Recently i have received to provide the sample size based on the Pharmacodynamic endpoints.

As we use the ISCV for the estimation of sample size in general Bioequivalence studies.

Can anyone have any idea how can we provide sample size for the PD endpopints


Responses are highly appreciated.:-)

Thanks all


Edit: Category changed; see also this post #1[Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,280 posts in 4,889 threads, 1,655 registered users;
72 visitors (0 registered, 72 guests [including 11 identified bots]).
Forum time: 22:43 CET (Europe/Vienna)

Freedom is always and exclusively
freedom for the one
who thinks differently.    Rosa Luxemburg

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5